Diffusing Capacity of the Lungs for Carbon Monoxide and Echocardiographic Parameters in Identifying Mild Pulmonary Hypertension in the EUSTAR Cohort of Patients With Systemic Sclerosis
CHEST · 2024
DOI: 10.1016/j.chest.2024.05.010 ↗Kurz gefasst
Fachartikel in der Zeitschrift CHEST, 2024. Verfasst von Amalia Colalillo und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy. Hauptthemen laut MEDLINE: Scleroderma, Systemic, Hypertension, Pulmonary, Pulmonary Diffusing Capacity, Carbon Monoxide. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: The 2022 European Society of Cardiology/European Respiratory Society guidelines define pulmonary hypertension (PH) as a resting mean pulmonary artery pressure (mPAP) > 20 mm Hg at right heart catheterization (RHC). Previously, patients with an mPAP between 21 and 24 mm Hg were classified in a "gray zone" of unclear clinical significance. RESEARCH QUESTION: What is the diagnostic performance of the main parameters used for PH screening in detecting patients with systemic sclerosis (SSc) with an mPAP of 21 to 24 mm Hg at RHC? STUDY DESIGN AND METHODS: Patients with SSc from the European Scleroderma Trials and Research (EUSTAR) database with available tricuspid annular plane systolic excursion (TAPSE), systolic PAP (sPAP), and mPAP data were included. Patients with mPAP 21 to 24 mm Hg and patients with mPAP ≤ 20 mm Hg were considered for the analysis. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy were calculated. RESULTS: TAPSE/sPAP was lower in the group of patients with SSc with mPAP 21 to 24 mm Hg than in the non-PH group (0.58 [0.46-0.72] vs 0.69 [0.57-0.81] mm/mm Hg, respectively; P < .01). No difference was found in other parameters between the two groups. Diffusing capacity of the lungs for carbon monoxide < 80% of the predicted value had the highest sensitivity (88.9%) and NPV (80%), but the lowest specificity (18.2%) and PPV (30.8%) in detecting patients with SSc with mPAP 21 to 24 mm Hg. TAPSE/sPAP < 0.55 mm/mm Hg had the highest specificity (78.9%), PPV (50%), and accuracy (68.1%); its NPV was 75.4%, and its sensitivity was 45.1%. INTERPRETATION: In this study, diffusing capacity of the lungs for carbon monoxide < 80% of the predicted value was the parameter with the highest sensitivity and NPV in detecting patients with SSc with mPAP 21 to 24 mm Hg. TAPSE/sPAP < 0.55 mm/mm Hg had the highest specificity, PPV, and accuracy and, therefore, can be a useful additional parameter to decrease the number of unnecessary RHCs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
- University of Lille, INSERM, CHU Lille, Department of Internal Medicine and Clinical Immunology, Hôpital Claude Huriez, CERAINOM, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille, France.
- Department of Internal Medicine and Department of Rheumatology, Ghent University Hospital, Ghent, Belgium; Unit for Molecular Immunology and Inflammation, VIB Inflammation Research Center (IRC), Ghent, Belgium.
- Department of Internal Medicine, University Hospital Erlangen, Erlangen, Germany.
- Department of Rheumatology and Clinical Immunology, University of Lübeck, Lübeck, Germany.
- Rheumatology Unit, Padova University Hospital, Padua, Italy.
Zitieren
APA
Colalillo, A., Hachulla, E., Pellicano, C., Smith, V., Bergmann, C., Riemekasten, G., Zanatta, E., Henes, J., Launay, D., Marcoccia, A., Gheorghiu, A. M., Truchetet, M. E., Iannone, F., Simeón Aznar, C. P., Oliveira, S., Vonk, M., Del Galdo, F., Rosato, E., & EUSTAR Collaborators (2024). Diffusing Capacity of the Lungs for Carbon Monoxide and Echocardiographic Parameters in Identifying Mild Pulmonary Hypertension in the EUSTAR Cohort of Patients With Systemic Sclerosis. CHEST. https://doi.org/10.1016/j.chest.2024.05.010
Vancouver
Colalillo A, Hachulla E, Pellicano C, Smith V, Bergmann C, Riemekasten G, et al. Diffusing Capacity of the Lungs for Carbon Monoxide and Echocardiographic Parameters in Identifying Mild Pulmonary Hypertension in the EUSTAR Cohort of Patients With Systemic Sclerosis. CHEST. 2024. doi:10.1016/j.chest.2024.05.010
BibTeX
@article{Colalillo2024,
author = {Colalillo, Amalia and Hachulla, Eric and Pellicano, Chiara and Smith, Vanessa and Bergmann, Christina and Riemekasten, Gabriela and Zanatta, Elisabetta and Henes, Jörg and Launay, David and Marcoccia, Antonella and Gheorghiu, Ana Maria and Truchetet, Marie-Elise and Iannone, Florenzo and Simeón Aznar, Carmen Pilar and Oliveira, Susana and Vonk, Madelon and Del Galdo, Francesco and Rosato, Edoardo and EUSTAR Collaborators, EUSTAR Collaborators},
title = {Diffusing Capacity of the Lungs for Carbon Monoxide and Echocardiographic Parameters in Identifying Mild Pulmonary Hypertension in the EUSTAR Cohort of Patients With Systemic Sclerosis},
journal = {CHEST},
year = {2024},
doi = {10.1016/j.chest.2024.05.010}
}
EUVIMED